Boston Scientific amended its credit agreement to extend the term, dated November 7, 2007, through February 7, 2019 and to increase the aggregate commitments to $400 million.

Wells Fargo served as administrative agent, lender and co-agent. Sumitomo Mitsui Banking, New York Branch also served as a lender, and SMBC Nikko Securities America served as co-agent.

The amendment also allows the lenders to extend credit directly or through conduits and at the request of the borrower, to extend LIBOR loans bearing interest by reference to LIBOR Market Index Rate.